UTI AMC’s (UTI) Q4FY23 performance was weak due to higher other expenses, and dip in AUM and operating revenue yields. Our thesis of employee cost rationalisation and better-than-peer growth driven by diversification (20% total revenues from non-MF businesses) remains valid.